A2.5-year-old girl underwent orthotopic liver transplantation (OLT) for cirrhosis secondary to progressive familial intrahepatic cholestasis. She was well until five days post-transplantation when she developed fever (up to 39 °C). At that time, she was receiving tacrolimus, cellcept and prednisolone. Her laboratory findings revealed a serum ALT of 70 IU/L, AST of 75 IU/L, Alk-P of 560 IU/L, and a total bilirubin of 2 mg/dL with a direct bilirubin of 0.7 mg/dL. Epstein-Barr virus capsid antigen and cytomegalovirus IgM were negative. Blood culture for fungus and bacteria were also negative. Photomicrograph of the biopsy is shown in [Figure 1](#F1){ref-type="fig"}.
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WHAT IS YOUR DIAGNOSIS?
=======================

Diagnosis: **Herpes Simplex Viral Hepatitis**

Herpes simplex (HSV) viral hepatitis is very rare in immunocompetent individuals \[[@B1]\]. Most of the cases have been reported in immunocompromised patients such as organ transplant recipients \[[@B2]\]. HSV hepatitis in transplanted liver is also rare and usually occurs as early as five days post-liver transplantation (median: 18 days) \[[@B3]\]. HSV infection is mostly due to the reactivation of a latent virus \[[@B4]\]. It seems that HSV hepatitis, as an early event, is most likely transmitted by the transplanted organ \[[@B5]\].

Though difficult, early diagnosis of HSV infection is very important. It can be diagnosed by PCR, isolation of the virus, and histopathology \[[@B4]\]. Histopathology of HSV hepatitis is characteristic---*i.e.*, well-defined foci of necrosis ([Fig 1](#F1){ref-type="fig"}), at the edge of which hepatocytes exhibit nuclei with amphophilic viral inclusions. ([Fig 1b](#F1){ref-type="fig"}, arrow) The inclusion bodies can be confirmed by immunohistochemical staining. The treatment of choice for HSV hepatitis is acyclovir \[[@B5]\]. Due to early diagnosis and prompt treatment, our patient survived and is doing well.
